ENTO ENTERO THERAPEUTICS INC Business Restructuring 8-K Filing 2024 - Acquisition and Default on Credit Agreement First Wave Biopharma, Inc. has acquired ImmunogenX, Inc. and is facing default on a credit agreement, resulting in the acceleration of outstanding obligations. Two board members have resigned, and the company is exploring options to maximize value for stakeholders.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC